{
 "edition": "20260917-18",
 "language": "en",
 "period_start": "2026-09-17T18:00:00+09:00",
 "period_end": "2026-09-17T21:00:00+09:00",
 "page": 3,
 "pages": 3,
 "received_in_period": 203,
 "listed_in_period": 203,
 "description": "One place for news and notices from 1 countries/regions: Taiwan, 203 items from 4 sources.One edition every 180 minutes: every item from every source received in the period, with the original link.",
 "countries": [
  {
   "code": "TW",
   "name": "Taiwan",
   "items": 203,
   "sources": 4
  }
 ],
 "number_of_items": 3,
 "items": [
  {
   "id": 2803942,
   "anchor": "n2803942",
   "permalink": "https://ainews.idaeo.ai/180m/20260917-18/index-en-p3.html#n2803942",
   "title": "承業醫 (4164): 富康 shareholders' meeting approves 李沛霖's reappointment as chairman - Global Bio & Investment Monthly",
   "title_state": "translated",
   "summary": "",
   "summary_state": "none",
   "facts": [],
   "companies": [
    "承業醫",
    "富康"
   ],
   "published_at": "2026-09-17T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90213&kind=21",
   "link_level": "source",
   "link_label": "Original",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2803941,
   "anchor": "n2803941",
   "permalink": "https://ainews.idaeo.ai/180m/20260917-18/index-en-p3.html#n2803941",
   "title": "高端疫苗二 (65472) bonds to be redeemed starting 10/8; OTC trading to end on 11/9 - Global Bio & Investment Monthly",
   "title_state": "translated",
   "summary": "",
   "summary_state": "none",
   "facts": [
    {
     "text": "Code: 65472",
     "state": "translated",
     "quote": "代碼：65472"
    }
   ],
   "companies": [
    "高端疫苗",
    "高端疫苗二"
   ],
   "published_at": "2026-09-17T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90214&kind=21",
   "link_level": "source",
   "link_label": "Original",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2803935,
   "anchor": "n2803935",
   "permalink": "https://ainews.idaeo.ai/180m/20260917-18/index-en-p3.html#n2803935",
   "title": "09/17 Bio Stock Updates - Global Bio & Investment Monthly",
   "title_state": "translated",
   "summary": "",
   "summary_state": "none",
   "facts": [
    {
     "text": "Capital reduction of NT$170 million",
     "state": "translated",
     "quote": "減資1.7億元"
    },
    {
     "text": "Paid-in capital of NT$100 million",
     "state": "translated",
     "quote": "實收資本額1億元"
    },
    {
     "text": "昱展新藥 9.94%",
     "state": "translated",
     "quote": "昱展新藥9.94%"
    },
    {
     "text": "禾榮科 9.85%",
     "state": "translated",
     "quote": "禾榮科9.85%"
    },
    {
     "text": "漢達 9.7%",
     "state": "translated",
     "quote": "漢達9.7%"
    },
    {
     "text": "浩宇生醫 9.09%",
     "state": "translated",
     "quote": "浩宇生醫9.09%"
    },
    {
     "text": "杏國 6.68%",
     "state": "translated",
     "quote": "杏國6.68%"
    },
    {
     "text": "睿生光電 6.28%",
     "state": "translated",
     "quote": "睿生光電6.28%"
    }
   ],
   "companies": [
    "通用幹細胞",
    "昱展新藥",
    "禾榮科",
    "漢達",
    "浩宇生醫",
    "杏國",
    "睿生光電"
   ],
   "published_at": "2026-09-17T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90224&range=news",
   "link_level": "source",
   "link_label": "Original",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  }
 ]
}